ArticleFrontiers in sports and active living2026
Strategic priorities and barriers to an effective anti-doping programme: views and opinions of European NADO leaders.
Article in Frontiers in sports and active living, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
National Anti-Doping Organizations (NADOs) play significant role in implementing the World Anti-Doping Code, yet little empirical research exists regarding their strategic priorities and perceptions about national and global anti-doping measures. This study explored the views of European NADO leaders on key areas for improving anti-doping programmes, perceived deterrent factors, and operational challenges. An online survey was distributed to 34 NADOs ahead of a 2025 European NADO conference; 32 (91%) NADO leaders responded. Across NADOs of all sizes, increased funding was the most frequently selected priority for improving both global (72%) and national (47%) anti-doping systems. Strengthening intelligence and investigation capacity (63%) and implementing values-based education (50%) were also considered essential for global improvement, while, improving testing effectiveness (41%) and expanding education programmes (31%) were key strategic aims within their own NADO. In contrast, increasing the number of tests or enhancing laboratory analyses were generally not considered a priority. More intensive anti-doping education was viewed as the most effective deterrent to prevent anti-doping rule violations (52%), followed by a higher perceived risk of detection (35%). Regarding risks of contamination, dietary supplements were widely regarded as high-risk for athletes in their country (68%), while environmental contamination was considered minimal risk. Major barriers to achieving strategic goals included insufficient funding (50%), limited human resources (31%), and inadequate political support (28%). These findings provide evidence-based insights into the shared challenges and strategic needs of European NADOs, informing future policy development and capacity building within anti-doping systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.